Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 15,390
-800 (-4.94%)
Oct 12, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 153.99 billion as of October 12, 2026. It is the 24,311th most valuable company in the world and the 1,029th biggest in South Korea. Its market cap has decreased by 37.57% in one year.
Market Cap
153.99B
Enterprise Value
111.31B
Revenue
8.37B
Global Rank
Country Rank
#1,029 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 153.99B, a decrease of -47.23%. That is a compound annual growth rate of -5.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 153.99B | -67.15% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 270.49B |
| HLB Therapeutics | 258.69B |
| GC Genome | 245.02B |
| GC Cell | 214.74B |
| Bioneer | 210.87B |
| Helixmith | 189.02B |
| NeoImmuneTech | 180.93B |
| Genexine | 127.12B |